Landscape and Saturation Analysis of Mutations Associated With Race in Cancer Genomes by Clinical Sequencing
Authors:
Open Access
- 31 January 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 29 (3) , 219-226
Abstract
Differences in cancer genomes between racial groups may impact tumor biology and health disparities. However, the discovery of race-associated mutations is constrained by the limited representation and sample size of different racial groups in prior genomic studies. We evaluated the influence of race on the frequency of gene mutations using the Genomics, Evidence, Neoplasia, Information, Exchange database, a large genomic dataset aggregated from clinical sequencing. Matched cohort analyses were used to identify histology-specific race-associated mutations including increased TERT promoter mutations in Black and Asian patients with gliomas and bladder cancers, and a decreased frequency of mutations in DNA repair pathway genes and subunits of the SWI/SNF chromatin complex in Asian and Black patients across multiple cancer types. The distribution of actionable mutations in oncogenes was also race-specific, demonstrating how targeted therapies may have a disparate impact on racial groups. Down-sampling analyses indicate that larger sample sizes are likely to discover more race-associated mutations. These results provide a resource to understand differences in cancer genomes between racial groups which may inform the design of clinical studies and patient recruitment strategies in biomarker trials.Keywords
This publication has 48 references indexed in Scilit:
- Racial/Ethnic Disparities in Genomic SequencingJAMA Oncology, 2016
- Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation ConsortiumCancer, 2015
- Comparison of the Genomic Landscape Between Primary Breast Cancer in African American Versus White Women and the Association of Racial Differences With Tumor RecurrenceJournal of Clinical Oncology, 2015
- Genomic Characterization of Non–Small-Cell Lung Cancer in African Americans by Targeted Massively Parallel SequencingJournal of Clinical Oncology, 2015
- Lack of reduction in racial disparities in cancer‐specific mortality over a 20‐year periodCancer, 2014
- Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy TrialJNCI: Journal of the National Cancer Institute, 2012
- Outcomes Among Black Patients With Stage II and III Colon Cancer Receiving Chemotherapy: An Analysis of ACCENT Adjuvant TrialsJNCI: Journal of the National Cancer Institute, 2011
- Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology GroupJNCI: Journal of the National Cancer Institute, 2009
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid CancersClinical Cancer Research, 2008
- Cancer Mortality in the United States by Education Level and RaceJNCI: Journal of the National Cancer Institute, 2007